Heteroaryl compounds and their use

The application is directed to compounds of formula (I): and their salts and solvates, wherein R1, R2, R3, A1, A2, A3, and n are as set forth in the specification, as well as to a method for their preparation, pharmaceutical compositions comprising the same, and use thereof for the treatment and/or...

Full description

Saved in:
Bibliographic Details
Main Authors GARCIA COLLAZO Ana Maria, BARRIL ALONSO Xavier, CUBERO JORDA Elena, REVES VILAPLANA Marc, ROBERTS Richard Spurring
Format Patent
LanguageEnglish
Hebrew
Published 01.04.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The application is directed to compounds of formula (I): and their salts and solvates, wherein R1, R2, R3, A1, A2, A3, and n are as set forth in the specification, as well as to a method for their preparation, pharmaceutical compositions comprising the same, and use thereof for the treatment and/or prevention of a lysosomal storage disease, such as Gaucher's, and other diseases or disorders that are synucleinopathies.
Bibliography:Application Number: IL20190267626